APO-Mometasone nasal spray recalled due to infection risk
Drug company Apotex is recalling two lots of its prescription nasal spray because of possible bacterial contamination.
![APO-Mometasone nasal spray recalled due to infection risk](https://i.cbc.ca/1.7120052.1708450380!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/apo-mometasone-nasal-spray.jpg)
![A nasal spray bottle and box for APO-Mometasone nasal spray, 50 mcg/metered spray. A nasal spray bottle and box for APO-Mometasone nasal spray.](https://i.cbc.ca/1.7120052.1708450380!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/apo-mometasone-nasal-spray.jpg)
Drug company Apotex is recalling two lots of its prescription nasal spray because of possible bacterial contamination.